Bausch + Lomb Corp (BLCO.TO) saw a notable uptick of 2.13% in its stock price during the last trading session, closing at CA$23.05.
In a market where many stocks are facing volatility, Bausch + Lomb Corp is making headlines with this solid gain. Investors are eager to understand whatโs driving this positive momentum for the eye health giant.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.09B
52W high
$25.70
52W low
$18.24
1W change
-3.75%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to fall 15.0% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.79
-15.0% Upside
Current Price
C$22.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
34.4%
Annualized
90-Day Vol
30.7%
Annualized
Trend (90d)
+11.0%
Annualized drift
90d Mean
C$22.98
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$22.39 | C$19.88 โ C$25.22 |
| 60 trading days | C$22.69 | C$19.18 โ C$26.84 |
| 90 trading days | C$22.98 | C$18.71 โ C$28.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent rise in Bausch + Lomb's stock price reflects investor confidence, likely fueled by positive sentiment surrounding its product offerings and market position.
2.13% Gain in One Day
Bausch + Lomb Corp's stock increased by CA$0.48, closing at CA$23.05, signaling a potential turnaround in investor sentiment.
Bull case
Bausch + Lomb has a strong reputation in the eye health sector, which may attract more investors. With a wide range of products, the company is well-positioned to benefit from the growing demand for eye care solutions.
Bear case
Despite the recent gain, Bausch + Lomb has faced challenges, including declining earnings per share over the last three years. Investors should stay cautious as the company navigates its financial landscape.
Market Overview
Bausch + Lomb's stock performance stands out in a challenging market environment. With a market cap of CA$8.22 billion, the company is a significant player in the eye health sector. The recent gain could indicate a broader recovery or renewed interest from investors.
Why the Rise?
The increase in Bausch + Lomb's stock price may be due to several factors, including positive news about their product lines and a potential shift in market sentiment. Investors are encouraged to keep an eye on the company's developments, especially considering its historical performance and recent challenges.
Looking Ahead
While the 2.13% gain is promising, investors should remain vigilant. Bausch + Lomb's past struggles with earnings could pose risks. For those interested in learning more about the company's financial health and future prospects, check out our in-depth analysis on Bausch + Lomb Corp.
Advertisement
